Program Description: 

The CRI Research Conference is aimed at academic faculty, residents and fellows and other research staff with an advanced level of pediatric knowledge.  This educational activity is designed to provide examples of research projects from hypothesis formulation to data collection and analysis.  Many projects presented in this forum have direct clinical relevance, and the unifying intent of this activity is to provide participant with innovation strategies and current information that impact sub-specialty care.

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Target audience: 

Academic faculty, residents and fellows and other research staff with an advanced level of pediatric knowledge.

Learning objectives: 
  1. To further the knowledge of the faculty in new areas of pediatric research.
  2. Expand the knowledge of pediatric faculty practitioners in the area of expanding research in the Department of Pediatrics and The Medical College of Wisconsin in order to promote the development of translational research at Children's Hospital of Wisconsin.
  3. Keep faculty up-to-date on cutting edge changes developing in the clinical care of children in subspecialty areas.
Faculty & credentials: 

The following planners have disclosed that they have no commercial interests:

Activity Directors:

Calvin Williams, MD, PhD
Ulrich Broeckel, MD


Ramani Ramchandran, PhD
Professor, Department of Pediatrics
Director, Developmental Vascular Biology Program
Medical College of Wisconsin


The following presenter has disclosed these commercial interests:

Name                                         Company                           Role   

Ramani Ramchandran, PhD             MCW                                See below

We are developing drugs that target the gene DUSP5 and is currently under patent protection at MCW.  However, we are only discussing part of this data in this presentation.  Other drugs that will be discussed are FDA-approved, and have been used for other indications.  We are suggesting re-purposing strategies for these drugs for vascular anomalies.  We are using generic names of these drugs in the presentation.





Linda L. Galecke
Phone number: 
+1 (414) 266-3010
Session date: 
02/12/2016 - 12:00pm to 1:00pm CST
Children's Auditorium
9000 West Wisconsin Avenue
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.